Literature DB >> 22569448

Posterior reversible encephalopathy syndrome in a patient with lupus nephritis.

Huseyin Kadikoy1, Waqar Haque, Vu Hoang, Joseph Maliakkal, John Nisbet, Abdul Abdellatif.   

Abstract

Posterior reversible encephalopathy syndrome (PRES) is characterized by acute onset of headache, nausea, focal neurological deficits or seizures along with radiological findings of white matter defects in the parietal and occipital lobes. Causes of PRES include uremia, hypertensive encephalopathy, eclampsia and immunosuppressive medications. Usually, the treatment of choice involves correcting the underlying abnormality. We describe an unusual case of recurrent PRES caused by uremia during a lupus flare in a patient with biopsy-proven Class IV Lupus Nephritis (LN) with vasculitis. PRES in systemic lupus erythematosis (SLE) is a rare clinical phenomenon and, when reported, it is associated with hypertensive encephalopathy. Our patient did not have hypertensive crisis, but had uremic encephalopathy. The patient's PRES-related symptoms resolved after initiation of hemodialysis. The temporal correlation of the correction of the uremia and the resolution of the symptoms of PRES show the etiology to be uremic encephalopathy, making this the first reported case of uremia-induced PRES in Class IV LN with vasculitis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22569448

Source DB:  PubMed          Journal:  Saudi J Kidney Dis Transpl        ISSN: 1319-2442


  9 in total

1.  A case of PRES in an active lupus nephritis patient after treatment of corticosteroid and cyclophosphamide.

Authors:  M Jabrane; Z Ait Lahcen; W Fadili; I Laouad
Journal:  Rheumatol Int       Date:  2014-11-12       Impact factor: 2.631

2.  A Rare Presentation of Lupus Nephritis Flare up with Posterior Reversible Leucoencephalopathy.

Authors:  S Hima Mani; S M Shivaprasad; L Umesh
Journal:  J Clin Diagn Res       Date:  2016-01-01

Review 3.  The multifactorial origin of posterior reversible encephalopathy syndrome in cyclophosphamide-treated lupus patients.

Authors:  Tatjana Zekić; Mirjana Stanić Benić; Ronald Antulov; Igor Antončić; Srđan Novak
Journal:  Rheumatol Int       Date:  2017-10-17       Impact factor: 2.631

4.  Posterior reversible encephalopathy syndrome with exercise-induced acute kidney injury in renal hypouricemia type 1.

Authors:  Shuichiro Fujinaga; Akira Ito; Mayu Nakagawa; Tsuneki Watanabe; Yoshiyuki Ohtomo; Toshiaki Shimizu
Journal:  Eur J Pediatr       Date:  2013-03-23       Impact factor: 3.183

Review 5.  Headache and vasculitis.

Authors:  J Ivan Lopez; Ashley Holdridge; Julio Chalela
Journal:  Curr Pain Headache Rep       Date:  2013-03

6.  Posterior reversible encephalopathy syndrome as the first clinical manifestation of lupus nephritis.

Authors:  Frederico Carvalho de Medeiros; Bárbara Márcia Rocha Sousa; Dandara Noária Cruz Santos; Gisele Novais Matias Sion; Cibele Fontes Alves
Journal:  Acta Neurol Belg       Date:  2021-02-16       Impact factor: 2.396

Review 7.  Posterior reversible encephalopathy syndrome in an adult patient undergoing peritoneal dialysis: a case report and literature review.

Authors:  Brett R Graham; George B Pylypchuk
Journal:  BMC Nephrol       Date:  2014-01-13       Impact factor: 2.388

8.  Obstructive ureteric calculus with superimposed infections causing reversible posterior leukoencephalopathy syndrome: A case report.

Authors:  Fei Xie; Yanli Cai; Lin Huang; Jianqiang Hao; Tianjin Ling; Seidu A Richard
Journal:  Medicine (Baltimore)       Date:  2021-04-23       Impact factor: 1.817

9.  Posterior Reversible Encephalopathy Syndrome in a Patient with Newly Diagnosed HIV Infection and End Stage Renal Disease.

Authors:  Mohankumar Kurukumbi; Maria I Castellanos; Amanda K Crawford; Shreyas D Gowdar; Annapurni Jayam-Trouth
Journal:  Case Rep Neurol Med       Date:  2013-04-30
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.